Incyte (INCY) Retained Earnings (2010 - 2026)
Incyte (INCY) posted Retained Earnings of $517.1 million for Q1 2026, up 141.9% on a QoQ basis from $213.8 million in Q4 2025, and up 156.53% year-over-year from $201.6 million in Q1 2025.
Incyte (INCY) Retained Earnings (2010 - 2026) Analysis & Trends
Incyte's Retained Earnings history runs 17 years deep, the most recent figure standing at $517.1 million for Q1 2026.
- Quarterly Retained Earnings rose 156.53% year-over-year to $517.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $517.1 million (up 156.53% YoY) and the FY2025 annual result came in at $213.8 million, up 1729.21% from the prior year.
- Retained Earnings was $517.1 million for Q1 2026 at Incyte, up from $213.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $517.1 million in Q1 2026 and bottomed at -$1.3 billion in Q3 2024.
- A 5-year average of -$231.4 million and a median of -$40.7 million in 2023 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 1729.21% in 2025, while the deepest fall reached 9303.67% in 2025.
- Incyte's Retained Earnings stood at -$437.2 million in 2022, then jumped by 136.68% to $160.4 million in 2023, then slumped by 108.18% to -$13.1 million in 2024, then soared by 1729.21% to $213.8 million in 2025, then jumped by 141.9% to $517.1 million in 2026.
- Business Quant data shows INCY's Retained Earnings at $517.1 million in Q1 2026, $213.8 million in Q4 2025, and $14.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 517.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 517.10 Mn |
| Dec 31, 2025 | 213.77 Mn |
| Sep 30, 2025 | 14.56 Mn |
| Jun 30, 2025 | -509.68 Mn |
| Mar 31, 2025 | -914.68 Mn |
| Dec 31, 2024 | -13.12 Mn |
| Sep 30, 2024 | -1.27 Bn |
| Jun 30, 2024 | -5.42 Mn |
| Mar 31, 2024 | 329.93 Mn |
| Dec 31, 2023 | 160.39 Mn |
| Sep 30, 2023 | -40.69 Mn |
| Jun 30, 2023 | -211.96 Mn |
| Mar 31, 2023 | -415.51 Mn |
| Dec 31, 2022 | -437.21 Mn |
| Sep 30, 2022 | -29.06 Mn |
| Jun 30, 2022 | -578.45 Mn |
| Mar 31, 2022 | -739.88 Mn |
| Dec 31, 2021 | -777.87 Mn |
| Sep 30, 2021 | -18.65 Mn |
| Jun 30, 2021 | -18.27 Mn |